In non-small cell lung cancer, miR-212 increases TRAIL-mediated cell death by targeting anti-apoptotic protein PED/PEA-15 (phosphoprotein enriched in astrocytes 15) [21] and targets synaptic acetylcholinesterase functioning as a tumor suppressor [53]. Here, TNFSF10 is linked to neoplasm.